Product
Grazax®
1 clinical trial
2 indications
Indication
Allergic RhinoconjunctivitisIndication
Seasonal Allergic RhinitisClinical trial
Grass Pollen Sublingual Tablet Immunotherapy Plus Dupilumab for Induction of Tolerance in Adults With Moderate to Severe Seasonal Allergic Rhinitis (ITN084AD)Status: Active (not recruiting), Estimated PCD: 2025-01-01